STOCK TITAN
  1. Home
  2. News
  3. INVO

INVO Bioscience Inc - INVO STOCK NEWS

Welcome to our dedicated news page for INVO Bioscience (Ticker: INVO), a resource for investors and traders seeking the latest updates and insights on INVO Bioscience.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect INVO Bioscience's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of INVO Bioscience's position in the market.

News
INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS
Rhea-AI Summary
INVO Bioscience, Inc. adjourns special meeting of shareholders to allow more time for voting on proposals. Proposal 1 to increase authorized shares has received affirmative vote of over 83% of shares casting votes. Proposal 2 to reduce exercise price for warrants has received affirmative vote of over 42% of shares casting votes. Shareholders encouraged to vote promptly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
Rhea-AI Summary
INVO Bioscience reminds shareholders to vote ahead of the Special Meeting on September 29, 2023. Board unanimously recommends voting 'FOR' all proposals. Shareholders as of August 21, 2023, can vote. Increase in authorized shares and reduction in exercise price for warrants among matters to be voted on.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
none
-
News
INVO Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
INVO Bioscience Announces Q2 2023 Financial Results and Business Update
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.68%
Tags
earnings
News
INVO Closes Acquisition of Wisconsin Fertility Institute
Rhea-AI Summary
INVO Bioscience, Inc. (Nasdaq: INVO) announces the acquisition of Wisconsin Fertility Institute, adding over $5 million in annual revenue, positive net income, and cash flows. The $10 million acquisition will enhance INVO's scale, operations, and commercial strategy, as well as complement its INVO Center strategy. The acquisition aligns with INVO's goal to democratize the fertility industry by leveraging its innovative INVOcell device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.82%
Tags
acquisition
-
News
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
Rhea-AI Summary
INVO Bioscience, Inc. (NASDAQ: INVO) to report financial results for its second quarter 2023 on August 14, 2023, after market close. The company will also conduct a conference call at 4:30 pm ET on the same day to review the results, offering interested parties call-in and webcast options for participation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.38%
Tags
conferences earnings
-
News
INVO Bioscience Announces Closing of $4.5 Million Public Offering
Rhea-AI Summary
INVO Bioscience closes public offering, raising approximately $4.5 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.66%
Tags
offering
News
INVO Bioscience Announces Pricing of $4.5 Million Public Offering
Rhea-AI Summary
INVO Bioscience, Inc. (Nasdaq:INVO) announced the pricing of its public offering of 1,580,000 units, each consisting of one share of common stock and two warrants, at a public offering price of $2.85 per unit. The gross proceeds are expected to be approximately $4.5 million. The offering is expected to close on August 8, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.71%
Tags
offering
-
News
INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.2%
Tags
acquisition
-
News
INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023
Rhea-AI Summary
INVO Bioscience, Inc. (Nasdaq: INVO) announced a 1-for-20 reverse stock split to comply with Nasdaq's minimum bid price requirement. The split will be effective on July 28, 2023, and the trading symbol will remain as 'INVO'. After the split, the company will have approximately 842,017 shares of common stock issued and outstanding.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.08%
Tags
none
News
INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.75%
Tags
clinical trial
Stock INVO logo
INVO Bioscience Inc

Nasdaq:INVO

INVO Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

INVO Stock Data

2.13M
2.45M
0.89%
4.34%
0.46%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Sarasota

About INVO

with the invocell and invo procedure, invo bioscience allows more and more patients to now receive safe, effective and affordable infertility treatment.